Thrombocytopenia Clinical Trials in Tianjin, Tianjin Municipality
28 recruitingTianjin, Tianjin Municipality, China
Showing 1–20 of 28 trials
Recruiting
Phase 1
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd.12 enrolled5 locationsNCT06880081
Recruiting
Phase 2
Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07362199
Recruiting
Phase 2
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China60 enrolled1 locationNCT06168851
Recruiting
Phase 1Phase 2
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06776510
Recruiting
Phase 2
Anti-CD38 Antibody Treating APS With Thrombocytopenia
ThrombocytopeniaAntiphospholipid Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled1 locationNCT05983952
Recruiting
Phase 2
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaRomiplostim N01
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT07063225
Recruiting
Phase 2
Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT07063199
Recruiting
Phase 1Phase 2
A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
Chronic Immune Thrombocytopenia
CASI pharmaceuticals, Inc.75 enrolled6 locationsNCT07017725
Recruiting
Phase 2
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China129 enrolled1 locationNCT06992128
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 2
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
TreatmentImmune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06799611
Recruiting
Phase 2
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
TreatmentImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT05214391
Recruiting
Phase 2
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
TreatmentThrombocytopeniaAntiphospholipid Syndrome
Institute of Hematology & Blood Diseases Hospital, China10 enrolled2 locationsNCT05199909
Recruiting
Phase 2
Avatrombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaAvatrombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05218226
Recruiting
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
ThrombocytopeniaSplenectomy
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT03998059
Recruiting
Phase 2
Herombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05236582
Recruiting
Phase 2
Eltrombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaEltrombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT04600960
Recruiting
Phase 2
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Primary immune thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China129 enrolled1 locationNCT06658834
Recruiting
Phase 2
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
Essential Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China40 enrolled1 locationNCT04226950